Prodrugs in cancer chemotherapy.
D006585:Altretamine / Q000378:metabolism; D000816:Aniline Mustard / Q000378:metabolism; D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000378:metabolism*; D001391:Azo Compounds / Q000378:metabolism; D001711:Biotransformation; D002626:Chemistry, Pharmaceutical; D003520:Cyclophosphamide / Q000378:metabolism; D003606:Dacarbazine / Q000378:metabolism; D004341:Drug Evaluation; D005260:Female; D005696:Galactosidases / Q000378:metabolism; D014453:Glucuronosyltransferase / Q000378:metabolism; D006801:Humans; D007093:Imidazoles / Q000378:metabolism; D008099:Liver / Q000201:enzymology; D008297:Male; D009325:Nausea / Q000139:chemically induced; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D009374:Neoplasms, Experimental / Q000188:drug therapy / Q000378:metabolism; D013329:Structure-Activity Relationship; D000077204:Temozolomide; D014839:Vomiting / Q000139:chemically induced
D000970:Antineoplastic Agents; D001391:Azo Compounds; D007093:Imidazoles; C011383:CB 10252; D003606:Dacarbazine; D003520:Cyclophosphamide; D000816:Aniline Mustard; D014453:Glucuronosyltransferase; D005696:Galactosidases; D006585:Altretamine; D000077204:Temozolomide